Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells

  • Authors:
    • Yunjuan Zhang
    • Lawrence Owusu
    • Wei Duan
    • Tao Jiang
    • Shizhu Zang
    • Ayaz Ahmed
    • Yi Xin
  • View Affiliations

  • Published online on: July 16, 2013     https://doi.org/10.3892/ijmm.2013.1446
  • Pages: 959-964
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third highest cause of cancer-related mortality in humans. Epigallocatechin-3-gallate (EGCG) has been shown to inhibit the metastatic activity of certain cancer cells. The aim of this study was to determine the effects and molecular mechanism(s) of action of EGCG in human HCC cells. A migration and invasion assay for the metastatic behavior of HCCLM6 cells was performed. The anti-metastatic effects of EGCG were investigated by RT-PCR and gelatin zymography. A total cellular protein profile was obtained using 2-dimensional gel electrophoresis (2-DE), followed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) analyses of proteins with significant differences in expression following treatment with EGCG. The results revealed that EGCG induced apoptosis and inhibited the metastasis of HCCLM6 cells. The anti-metastatic effects of EGCG were associated with the inhibition of matrix metalloproteinase (MMP)-2 and MMP-9 activity. The expression levels of far upstream element (FUSE) binding protein 1 (FUBP1), heat shock protein beta 1 (HSPB1), heat shock 60 kDa protein 1 (chaperonin) (CH60) and nucleophosmin (NPM) proteins, which are associated with metastasis, were significantly altered in the EGCG-treated HCCLM6 cells. The data from the present study suggest that EGCG has potential as a therapeutic agent for the treatment of HCC.
View Figures
View References

Related Articles

Journal Cover

October 2013
Volume 32 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Owusu L, Duan W, Jiang T, Zang S, Ahmed A and Xin Y: Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells. Int J Mol Med 32: 959-964, 2013
APA
Zhang, Y., Owusu, L., Duan, W., Jiang, T., Zang, S., Ahmed, A., & Xin, Y. (2013). Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells. International Journal of Molecular Medicine, 32, 959-964. https://doi.org/10.3892/ijmm.2013.1446
MLA
Zhang, Y., Owusu, L., Duan, W., Jiang, T., Zang, S., Ahmed, A., Xin, Y."Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells". International Journal of Molecular Medicine 32.4 (2013): 959-964.
Chicago
Zhang, Y., Owusu, L., Duan, W., Jiang, T., Zang, S., Ahmed, A., Xin, Y."Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells". International Journal of Molecular Medicine 32, no. 4 (2013): 959-964. https://doi.org/10.3892/ijmm.2013.1446